Darrell Salk

2.1k total citations
53 papers, 1.7k citations indexed

About

Darrell Salk is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Darrell Salk has authored 53 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Genetics. Recurrent topics in Darrell Salk's work include DNA Repair Mechanisms (16 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Darrell Salk is often cited by papers focused on DNA Repair Mechanisms (16 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Darrell Salk collaborates with scholars based in United States, Germany and Netherlands. Darrell Salk's co-authors include Holger Hoehn, George M. Martin, Kit Sing Au, Jonas Salk, Eileen Bryant, Thomas H. Norwood, Christine M. Distèche, Karen Swisshelm, Yoshisada Fujiwara and Joanne L. Thorvaldsen and has published in prestigious journals such as Science, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Darrell Salk

53 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darrell Salk United States 22 998 340 223 220 213 53 1.7k
Michael Nunn United States 15 862 0.9× 67 0.2× 328 1.5× 99 0.5× 123 0.6× 25 1.7k
Kurt Stromberg United States 27 992 1.0× 139 0.4× 270 1.2× 80 0.4× 178 0.8× 57 2.2k
Shih‐Hsing Leir United States 24 904 0.9× 325 1.0× 241 1.1× 47 0.2× 194 0.9× 66 2.0k
Ann Atzberger Germany 23 894 0.9× 274 0.8× 104 0.5× 60 0.3× 116 0.5× 36 2.4k
P. Couillin France 23 999 1.0× 56 0.2× 328 1.5× 62 0.3× 67 0.3× 60 1.5k
Chenguang Xu China 15 514 0.5× 76 0.2× 79 0.4× 171 0.8× 120 0.6× 36 1.9k
P. H. Fitzgerald New Zealand 28 888 0.9× 149 0.4× 755 3.4× 381 1.7× 203 1.0× 109 2.7k
H. Sobis Belgium 21 450 0.5× 145 0.4× 364 1.6× 30 0.1× 65 0.3× 74 2.0k
N Talal United States 20 359 0.4× 339 1.0× 238 1.1× 42 0.2× 34 0.2× 43 1.7k
Nadine Zangger Switzerland 19 938 0.9× 178 0.5× 123 0.6× 64 0.3× 203 1.0× 27 2.1k

Countries citing papers authored by Darrell Salk

Since Specialization
Citations

This map shows the geographic impact of Darrell Salk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darrell Salk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darrell Salk more than expected).

Fields of papers citing papers by Darrell Salk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darrell Salk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darrell Salk. The network helps show where Darrell Salk may publish in the future.

Co-authorship network of co-authors of Darrell Salk

This figure shows the co-authorship network connecting the top 25 collaborators of Darrell Salk. A scholar is included among the top collaborators of Darrell Salk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darrell Salk. Darrell Salk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vansant, Johnathan P., David H. Johnson, James R. Stewart, et al.. (1992). Staging Lung Carcinoma with a Tc-99m Labeled Monoclonal Antibody. Clinical Nuclear Medicine. 17(6). 431–438. 21 indexed citations
2.
Blend, Michael J., Salve G. Ronan, Darrell Salk, & Tapas K. Das Gupta. (1992). Role of technetium 99m-labeled monoclonal antibody in the management of melanoma patients.. Journal of Clinical Oncology. 10(8). 1330–1337. 14 indexed citations
3.
Balaban, Edward P., Brandy S. Walker, John V. Cox, et al.. (1992). Detection and Staging of Small Cell Lung Carcinoma with a Technetium-labeled Monoclonal Antibody A Comparison with Standard Staging Methods. Clinical Nuclear Medicine. 17(6). 439–445. 19 indexed citations
4.
Balaban, Edward P., Brandy S. Walker, John V. Cox, et al.. (1991). Radionuclide Imaging of Bone Marrow Metastases with a Tc-99m Labeled Monoclonal Antibody to Small Cell Lung Carcinoma. Clinical Nuclear Medicine. 16(10). 732–736. 9 indexed citations
5.
Frytak, Stephen, Edward T. Creagan, M L Brown, Darrell Salk, & W. B. Nelp. (1991). A Technetium-Labeled Monoclonal Antibody for Imaging Metastatic Melanoma. American Journal of Clinical Oncology. 14(2). 156–161. 8 indexed citations
6.
Swisshelm, Karen, Christine M. Distèche, Joanne L. Thorvaldsen, Andrew Nelson, & Darrell Salk. (1990). Age-related increase in methylation of ribosomal genes and inactivation of chromosome-specific rRNA gene clusters in mouse. Mutation Research/DNAging. 237(3-4). 131–146. 65 indexed citations
7.
Friedman, Stanford B., K. Sullivan, Darrell Salk, et al.. (1990). Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies.. PubMed. 4(6). 1069–78. 15 indexed citations
8.
Swartz, T. A., Rachel Handsher, P Stoeckel, et al.. (1989). Immunologic memory induced at birth by immunization with inactivated polio vaccine in a reduced schedule. European Journal of Epidemiology. 5(2). 143–145. 26 indexed citations
9.
Serafini, A. N., Jon Kotler, Lynn G. Feun, et al.. (1989). Technetium-99m Labeled Monoclonal Antibodies in the Detection of Metastatic Melanoma. Clinical Nuclear Medicine. 14(8). 580–587. 10 indexed citations
10.
Drummond‐Borg, Margaret, et al.. (1988). Nonfluorescent dicentric Y in males with hypospadias. The Journal of Pediatrics. 113(3). 469–473. 4 indexed citations
11.
Sybert, Virginia P., Cynthia M. Bradley, & Darrell Salk. (1988). Mosaicism for ring 19: a case report. Clinical Genetics. 34(6). 382–385. 10 indexed citations
12.
Salk, Darrell. (1988). Polio immunization policy in the United States: a new challenge for a new generation.. American Journal of Public Health. 78(3). 296–300. 11 indexed citations
13.
Siebert, Joseph R., et al.. (1987). Duplication 7p in a family with t(7;11): Association with anomalies of the anterior cranial base. American Journal of Medical Genetics. 27(3). 687–692. 14 indexed citations
14.
Salk, Darrell, Yoshisada Fujiwara, & George M. Martin. (1985). Werner’s Syndrome and Human Aging. Advances in experimental medicine and biology. 41 indexed citations
15.
Pendergrass, W., et al.. (1985). Induction of DNA polymerase α in senescent cultures of normal and Werner's syndrome cultured skin fibroblasts. Journal of Cellular Physiology. 124(2). 331–336. 25 indexed citations
16.
Salk, Darrell. (1985). In Vitro Studies of Werner Syndrome Cells: Aberrant Growth and Chromosome Behavior. PubMed. 35. 419–426. 10 indexed citations
17.
Bettecken, Thomas, et al.. (1984). Flow cytometric analysis of small DNA content differences in heterogeneous cell populations: Human amniotic fluid cells. Cytometry. 5(2). 118–123. 16 indexed citations
18.
Kubbies, Manfred, et al.. (1983). Decreased oxygen supply enhances growth in culture of human mid-trimester amniotic fluid cells. Human Genetics. 64(4). 334–338. 8 indexed citations
19.
Hoehn, Holger & Darrell Salk. (1982). Chapter 2. Morphological and Biochemical Heterogeneity of Amniotic Fluid Cells in Culture. Methods in cell biology. 26. 11–34. 88 indexed citations
20.
Salk, Darrell, Kit Sing Au, Holger Hoehn, & George M. Martin. (1981). Cytogenetics of Werner’s syndrome cultured skin fibroblasts: variegated translocation mosaicism. Cytogenetic and Genome Research. 30(2). 92–107. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Nunn Breakdown of academic impact, for papers by Kurt Stromberg Breakdown of academic impact, for papers by Shih‐Hsing Leir Breakdown of academic impact, for papers by Ann Atzberger Breakdown of academic impact, for papers by P. Couillin Breakdown of academic impact, for papers by Chenguang Xu Breakdown of academic impact, for papers by P. H. Fitzgerald Breakdown of academic impact, for papers by H. Sobis Breakdown of academic impact, for papers by N Talal Breakdown of academic impact, for papers by Nadine Zangger
Rankless by CCL
2026